Roche (OTCMKTS:RHHBY) Sets New 1-Year High - Should You Buy?

Key Points

• Shares of Roche Holding AG reached a new 52-week high, trading as high as $45.94, indicating strong market interest.
• Analysts have upgraded Roche's rating to "buy" and set a price target of $50.00, reflecting positive sentiment from financial analysts.
• Institutional investors have recently increased their stakes in Roche, with notable increases from companies like GAMMA Investing LLC and North Star Asset Management Inc.

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $45.94 and last traded at $45.83, with a volume of 3374063 shares. The stock had previously closed at $45.15.

Analysts Set New Price Targets

RHHBY has been the subject of a number of research analyst reports. HSBC upgraded Roche from a "hold" rating to a "buy" rating and set a $50.00 price objective for the company in a report on Thursday, October 2nd. Hsbc Global Res upgraded Roche from a "hold" rating to a "strong-buy" rating in a report on Thursday, October 2nd. Three research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $50.00.

Roche Trading Up 1.2%

The business's 50-day moving average is $40.95 and its two-hundred day moving average is $40.27.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. GAMMA Investing LLC lifted its stake in shares of Roche by 17.4% in the third quarter. GAMMA Investing LLC now owns 18,899 shares of the company's stock worth $790,000 after acquiring an additional 2,798 shares in the last quarter. Knuff & Co LLC acquired a new position in shares of Roche in the second quarter worth about $255,000. North Star Asset Management Inc. lifted its stake in shares of Roche by 52.0% in the second quarter. North Star Asset Management Inc. now owns 26,305 shares of the company's stock worth $1,072,000 after acquiring an additional 9,000 shares in the last quarter. Enterprise Financial Services Corp acquired a new position in shares of Roche in the second quarter worth about $208,000. Finally, Rhumbline Advisers lifted its stake in shares of Roche by 1.1% in the second quarter. Rhumbline Advisers now owns 108,480 shares of the company's stock worth $4,422,000 after acquiring an additional 1,228 shares in the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.